РусскийEnglish (UK)
     
 

Публикации с 2016 года

Кол-во строк: 
# Заголовок
31 PPAR in Cardiovascular Disorders.

Orekhov AN, Mukhamedova N, Ivanova EA, Rizzo M.
PPAR Res. 2016;2016:6293629. doi: 10.1155/2016/6293629. Epub 2016 Jul 26.

32 Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.

Myasoedova VA, Kirichenko TV, Melnichenko AA, Orekhova VA, Ravani A, Poggio P, Sobenin IA, Bobryshev YV, Orekhov AN.
Int J Mol Sci. 2016 Aug 11;17(8). pii: E1318. doi: 10.3390/ijms17081318.

33 Evidence based efficacy of herbal preparations in ageing associated cardiovascular disorders.

Orekhov AN

Phytomedicine. 2016 Oct 15;23(11):1065-7. doi: 10.1016/j.phymed.2016.07.014.

 

34 Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis.

Bobryshev YV, Ivanova EA, Chistiakov DA, Nikiforov NG, Orekhov AN

 2016;2016:9582430. doi: 10.1155/2016/9582430. Epub 2016 Jul 17.

35 Effects of shear stress on endothelial cells: go with the flow.

Chistiakov DA, Orekhov AN, Bobryshev YV

Acta Physiol (Oxf). 2016 Jun 1. doi: 10.1111/apha.12725. [Epub ahead of print]

36 Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.

Chistiakov DA, Orekhov AN, Bobryshev YV

Immunobiology. 2016 May 24. pii: S0171-2985(16)30081-X. doi: 10.1016/j.imbio.2016.05.010. [Epub ahead of print]

37 [Epigenetic factors in atherogenesis: microRNA].

Smirnova AV, Sukhorukov VN, Karagodin VP, Orekhov AN.

Biomed Khim. 2016 Feb;62(2):134-140. doi: 10.18097/PBMC20166202134.

38 LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.

Chistiakov DA, Orekhov AN, Bobryshev YV.

Cell Physiol Biochem. 2016;38(5):1851-9. doi: 10.1159/000443123. Epub 2016 May 9.

39 The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease.

Chistiakov DA1, Orekhov AN2, Bobryshev YV3.
J Mol Cell Cardiol. 2016 May 12;97:47-55. doi: 10.1016/j.yjmcc.2016.05.007. [Epub ahead of print]

40 ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.

Chistiakov DA, Orekhov AN, Bobryshev YV

Lab Invest. 2016 May 16. doi: 10.1038/labinvest.2016.56. [Epub ahead of print]